Antegenes secures €2.3 million to advance personalised cancer prevention

Healthtech startup Antegenes are pioneering a personalised approach to cancer prevention. The innovative company has now raised a total of €2.3 million and is ready to bring its tests to new markets across Europe.

Cancer is one of the most prevalent and deadly diseases facing society. It’s reported that 1 in 2 people will develop some form of cancer during their lifetime. It’s a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs – and there are an estimated 200 different types. The sad reality is that all of us will be impacted at one point – whether directly or indirectly. 

One of the key ways to tackle cancer and have a chance of overcoming it is prevention. And this is what Antegenes want to advance – developing a personalised cancer prevention test. 

Founded in 2018, Antegenes’ novel genetic tests assess patients’ personal cancer risks and include clinical recommendations for further personalised cancer prevention. Tests are based on innovative polygenic risk score technology which helps to clarify an individual’s genetic predispositions to cancer.

It, therefore, allows for more accurate prevention and early detection measures – crucial in the fight against cancer. The tests are currently used to determine the genetic risk to four cancers: breast cancer, prostate cancer, colon cancer, and skin melanoma.

The startup has just raised €2.3 million for its pioneering genetic tests. 

The Tartu-based startup received €1.6 million from investors in a Seed round which was led by Pipedrive co-founder Timo Rein, Pipedrive’s first investor Peep Vain and entrepreneurs Aare Kurist and Andreas Henn Otsmaa. Other Estonian investors and entrepreneurs participated in the round. The financing round was advised by investment banking company Keystone Advisers and law firm Sorainen.

On top of this, Antegenes received two grants to bring research-intensive innovation to international healthcare. The first is from the BRIGHT Project, financed by EIT Health, which supplied €500k to the healthtech team.  At the centre of the project is Antegenes and the breast cancer genetic risk test AnteBC. The aim is to implement the AnteBC test in breast cancer precision prevention in Estonia, Portugal and Sweden, with further developments in Europe more broadly. 

Partners of the project are the University of Tartu, IESE Business School, Tartu University Hospital, Estonian Health Insurance Fund, Uppsala University Hospital, North Lisbon University Hospital Centre, and GE Healthcare.

The second grant came from the Norway Grants Green ICT programme, which supports business cooperation between Estonia and Norway. The €200k grant will be used to implement the AnteBC test as part of a breast cancer screening routine in Norway. The partners of the project are the University of Oslo, Oslo University Hospital, Vestre Viken Hospital Trust, and Oslo Cancer Cluster. 

A little progress each day adds up to big results. Congratulations to the entire team at Antegenes on your funding. I wish you great success in your endeavours.

Shishir Gupta, Founder and CEO, StartupLanes

Don’t keep wondering about funding, you can also raise funds. Learn how to raise funds here: Yes I want to raise funds.

If you are an emerging startup and are looking for investors to raise funds, StartupLanes has its own angel network and investment banking services and is connected to angel investors and VCs in 15 countries that ensure that our member startups have easy access to external funds to scale up constantly.

You can subscribe to our news posts by entering your email in the box on the right side of this page.

Check out our YouTube channel for insightful content from the Indian startup ecosystem.

Or join our Whatsapp group to interact with other founders: Yes, I want to join the Whatsapp group.

The right investment is key to beating inflation and growing your wealth. Do you wish to become an angel investor? Yes, I want to be an angel investor.

Are you a startup and facing challenges in your business? Do you want to grow your business? It is not as difficult as it sounds. Learn how to grow your business here- Yes, I want to grow my business.

For any rectifications, reach out to nicole@startuplanes.com